Sale!

DYSF Gene Myopathy Distal with Anterior Tibial Onset Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “DYSF Gene Myopathy Distal with Anterior Tibial Onset Genetic Test” is a specialized diagnostic assessment designed to identify mutations in the DYSF gene, which are implicated in a rare form of muscular dystrophy known as Dysferlinopathy. This condition is characterized by muscle weakness and atrophy, initially affecting the anterior tibial muscles in the legs, and can progressively involve other muscle groups. The test is crucial for confirming the diagnosis, understanding the disease progression, and guiding treatment options.

Performed at DNA Labs UAE, the test involves analyzing the patient’s DNA to detect specific genetic alterations in the DYSF gene. The process requires a sample of the patient’s blood or saliva, from which DNA is extracted and examined for the presence of mutations associated with the condition.

The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the genetic analysis and the specialized expertise required to interpret the results. By providing a definitive diagnosis, this test plays a vital role in the management of patients with symptoms suggestive of Dysferlinopathy, enabling targeted interventions and genetic counseling for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DYSF Gene Myopathy Distal with Anterior Tibial Onset Genetic Test

Genetic testing is an important tool in diagnosing and managing rare genetic disorders like DYSF gene myopathy, distal with anterior tibial onset. This genetic test, offered by DNA Labs UAE, can help identify mutations or variations in the DYSF gene that may be causing the condition.

Test Details

DYSF gene myopathy, distal with anterior tibial onset, is a rare genetic disorder characterized by muscle weakness and wasting, primarily affecting the distal muscles, particularly the anterior tibial muscles in the lower legs. This condition is caused by mutations in the DYSF gene, which provides instructions for making a protein called dysferlin.

NGS genetic testing, or Next-Generation Sequencing genetic testing, is a high-throughput sequencing technology used to analyze multiple genes simultaneously. It allows for the detection of various genetic mutations and can be particularly useful in diagnosing rare genetic disorders like DYSF gene myopathy.

NGS genetic testing for DYSF gene myopathy involves sequencing the DYSF gene to identify any mutations or variations that may be causing the condition. This can help confirm a diagnosis and provide important information for disease management and genetic counseling.

Test Components and Price

  • Test Name: DYSF Gene Myopathy Distal with Anterior Tibial Onset Genetic Test
  • Components: NGS Technology
  • Price: 4400.0 AED

Sample Condition

Patients can provide a blood sample, extracted DNA, or one drop of blood on an FTA card for the test.

Report Delivery

The test results will be delivered within 3 to 4 weeks.

Test Type and Department

The test type is Neurological Disorders, and it falls under the Genetics department.

Referring Doctor

Neurologists are the doctors who can refer patients for this genetic test.

Pre-Test Information

Before undergoing the DYSF Gene Myopathy Distal with Anterior Tibial Onset Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by DYSF Gene Myopathy, distal with anterior tibial onset. This information can help in the interpretation of the test results and provide valuable insights for disease management and genetic counseling.

It is advisable to consult with a healthcare professional or a genetic counselor to discuss the appropriateness and availability of NGS genetic testing for DYSF gene myopathy, as they can provide more specific information and guidance based on individual circumstances.

Test Name DYSF Gene Myopathy distal with anterior tibial onset Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DYSF Gene Myopathy, distal with anterior tibial onset NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DYSF Gene Myopathy, distal with anterior tibial onset
Test Details

DYSF gene myopathy, distal with anterior tibial onset, is a rare genetic disorder characterized by muscle weakness and wasting that primarily affects the distal muscles, particularly the anterior tibial muscles in the lower legs. This condition is caused by mutations in the DYSF gene, which provides instructions for making a protein called dysferlin.

NGS genetic testing, or Next-Generation Sequencing genetic testing, is a high-throughput sequencing technology used to analyze multiple genes simultaneously. It allows for the detection of various genetic mutations and can be particularly useful in diagnosing rare genetic disorders like DYSF gene myopathy.

NGS genetic testing for DYSF gene myopathy involves sequencing the DYSF gene to identify any mutations or variations that may be causing the condition. This can help confirm a diagnosis and provide important information for disease management and genetic counseling.

It is important to consult with a healthcare professional or a genetic counselor to discuss the appropriateness and availability of NGS genetic testing for DYSF gene myopathy, as they can provide more specific information and guidance based on individual circumstances.